Outcomes | 3-dose group (n = 27) | 4-dose group (n = 27) | p-value |
---|---|---|---|
Anamnestic response | 7 (25.9%) | 9 (33.3%) | 0.551 |
High-level responders at week 4 | 0 (0%) | 1 (3.7%) | 1.000 |
Responders at week 28 | 23 (85.2%) | 24 (88.9%) | 1.000 |
High-level responders at week 28 | 12 (44.4%) | 17 (63.0%) | 0.172 |
GMT of anti-HBs Ab at week 4 (95% CI) | 4.4 (2.1–8.4) | 5.29 (2.4–10.8) | 0.714 |
GMT of anti-HBs Ab at week 28 (95% CI) | 63.8 (31.4–128.7) | 209.8 (90.0–487.4) | 0.030 |